Monoamine Oxidase and Decarboxylase Inhibitors as Antihypertensive Agents
- 1 March 1961
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 45 (2) , 421-428
- https://doi.org/10.1016/s0025-7125(16)33904-9
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINEAnnals of the New York Academy of Sciences, 1960
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- Quantitation of Monoamine Oxidase Inhibition Produced with Various Drugs in Man.Experimental Biology and Medicine, 1960
- FATAL JAUNDICE AFTER ADMINISTRATION OF BETA-PHENYLISOPROPYLHYDRAZINEJAMA, 1959
- Alterations in the Pattern of Amine Excretion in Man Produced by a Monoamine Oxidase InhibitorScience, 1959
- The application of a monoamine-oxidase inhibitor, 1-phenyl-2-hydrazinopropane (JB-516), to the treatment of primary hypertensionAmerican Heart Journal, 1959
- Ganglionic Block and Monoamine Oxidase InhibitorsNature, 1959
- ISONIAZID AS A CAUSE OF OPTIC NEURITIS AND ATROPHYJAMA, 1957